BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Howes N, Greenhalf W, Rutherford S, O'Donnell M, Mountford R, Ellis I, Whitcomb D, Imrie C, Drumm B, Neoptolemos JP. A new polymorphism for the RI22H mutation in hereditary pancreatitis. Gut 2001;48:247-50. [PMID: 11156648 DOI: 10.1136/gut.48.2.247] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Masson E, Zou WB, Génin E, Cooper DN, Le Gac G, Fichou Y, Pu N, Rebours V, Férec C, Liao Z, Chen JM. Expanding ACMG variant classification guidelines into a general framework. Hum Genomics 2022;16:31. [PMID: 35974416 DOI: 10.1186/s40246-022-00407-x] [Reference Citation Analysis]
2 Pereira SP, Oldfield L, Ney A, Hart PA, Keane MG, Pandol SJ, Li D, Greenhalf W, Jeon CY, Koay EJ, Almario CV, Halloran C, Lennon AM, Costello E. Early detection of pancreatic cancer. Lancet Gastroenterol Hepatol. 2020;5:698-710. [PMID: 32135127 DOI: 10.1016/s2468-1253(19)30416-9] [Cited by in Crossref: 102] [Cited by in F6Publishing: 96] [Article Influence: 51.0] [Reference Citation Analysis]
3 Sultan M, Werlin S, Venkatasubramani N. Genetic prevalence and characteristics in children with recurrent pancreatitis. J Pediatr Gastroenterol Nutr. 2012;54:645-650. [PMID: 22094894 DOI: 10.1097/mpg.0b013e31823f0269] [Cited by in Crossref: 39] [Cited by in F6Publishing: 16] [Article Influence: 3.9] [Reference Citation Analysis]
4 Rebours V, Lévy P, Ruszniewski P. An overview of hereditary pancreatitis. Dig Liver Dis. 2012;44:8-15. [PMID: 21907651 DOI: 10.1016/j.dld.2011.08.003] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
5 Joergensen MT, Geisz A, Brusgaard K, Schaffalitzky de Muckadell OB, Hegyi P, Gerdes AM, Sahin-Tóth M. Intragenic duplication: a novel mutational mechanism in hereditary pancreatitis. Pancreas 2011;40:540-6. [PMID: 21499207 DOI: 10.1097/MPA.0b013e3182152fdf] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
6 Szmola R, Sahin-Tóth M. Uncertainties in the classification of human cationic trypsinogen (PRSS1) variants as hereditary pancreatitis-associated mutations. J Med Genet 2010;47:348-50. [PMID: 20452997 DOI: 10.1136/jmg.2009.072751] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
7 Derikx MH, Drenth JP. Genetic factors in chronic pancreatitis; implications for diagnosis, management and prognosis. Best Practice & Research Clinical Gastroenterology 2010;24:251-70. [DOI: 10.1016/j.bpg.2010.02.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
8 Frulloni L, Scattolini C, Graziani R, Cavestro GM, Pravadelli C, Amodio A, Manfredi R, Scarpa A, Vantini I. Clinical and Radiological Outcome of Patients Suffering From Chronic Pancreatitis Associated With Gene Mutations: . Pancreas 2008;37:371-6. [DOI: 10.1097/mpa.0b013e31817f52a1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
9 Teich N, Mössner J. Hereditary chronic pancreatitis. Best Pract Res Clin Gastroenterol 2008;22:115-30. [PMID: 18206817 DOI: 10.1016/j.bpg.2007.10.019] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
10 Schneider A, Pfützer R, Whitcomb DC. Genetics and pancreatic disease. Curr Opin Gastroenterol 2002;18:545-51. [PMID: 17033331 DOI: 10.1097/00001574-200209000-00004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
11 Rosendahl J, Bödeker H, Mössner J, Teich N. Hereditary chronic pancreatitis. Orphanet J Rare Dis. 2007;2:1. [PMID: 17204147 DOI: 10.1186/1750-1172-2-1] [Cited by in Crossref: 67] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
12 Teich N, Rosendahl J, Tóth M, Mössner J, Sahin-Tóth M. Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis. Hum Mutat. 2006;27:721-730. [PMID: 16791840 DOI: 10.1002/humu.20343] [Cited by in Crossref: 82] [Cited by in F6Publishing: 79] [Article Influence: 5.1] [Reference Citation Analysis]
13 Vitone LJ, Greenhalf W, Howes NR, Raraty MG, Neoptolemos JP. Trypsinogen Mutations in Pancreatic Disorders. Endocrinology and Metabolism Clinics of North America 2006;35:271-87. [DOI: 10.1016/j.ecl.2006.02.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
14 Ahmad-Nejad P, Dorn-Beineke A, Pfeiffer U, Brade J, Geilenkeuser WJ, Ramsden S, Pazzagli M, Neumaier M. Methodologic European external quality assurance for DNA sequencing: the EQUALseq program. Clin Chem 2006;52:716-27. [PMID: 16439604 DOI: 10.1373/clinchem.2005.061572] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
15 Maire F. [Genetic testing for acute or chronic pancreatitis]. Gastroenterol Clin Biol 2005;29:715-23. [PMID: 16142007 DOI: 10.1016/s0399-8320(05)82161-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
16 Wang XL, Wang J. Smoking-gene interaction and disease development: relevance to pancreatic cancer and atherosclerosis. World J Surg 2005;29:344-53. [PMID: 15696395 DOI: 10.1007/s00268-004-7819-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
17 Otsuki M, Nishimori I, Hayakawa T, Hirota M, Ogawa M, Shimosegawa T; Research Committee on Intractable Disease of the Pancreas. Hereditary pancreatitis: clinical characteristics and diagnostic criteria in Japan. Pancreas 2004;28:200-6. [PMID: 15028953 DOI: 10.1097/00006676-200403000-00012] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
18 Howes N, Greenhalf W, Stocken DD, Neoptolemos JP. Cationic Trypsinogen Mutations and Pancreatitis. Clinics in Laboratory Medicine 2005;25:39-59. [DOI: 10.1016/j.cll.2004.12.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
19 Howes N, Greenhalf W, Stocken DD, Neoptolemos JP. Cationic trypsinogen mutations and pancreatitis. Gastroenterol Clin North Am 2004;33:767-87. [PMID: 15528017 DOI: 10.1016/j.gtc.2004.07.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
20 Ellis I. Genetic counseling for hereditary pancreatitis – the role of molecular genetics testing for the cationic trypsinogen gene, cystic fibrosis and serine protease inhibitor Kazal type 1. Gastroenterology Clinics of North America 2004;33:839-54. [DOI: 10.1016/j.gtc.2004.07.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
21 Alexakis N, Connor S, Ghaneh P, Raraty M, Lombard M, Smart H, Evans J, Hughes M, Garvey C, Goulden M, Parker C, Sutton R, Neoptolemos J. Influence of opioid use on surgical and long-term outcome after resection for chronic pancreatitis. Surgery 2004;136:600-8. [DOI: 10.1016/j.surg.2004.02.011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
22 Alexakis N, Sutton R, Raraty M, Connor S, Ghaneh P, Hughes ML, Garvey C, Evans JC, Neoptolemos JP. Major resection for chronic pancreatitis in patients with vascular involvement is associated with increased postoperative mortality. British Journal of Surgery 2004;91:1020-6. [DOI: 10.1002/bjs.4616] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
23 Howes N, Lerch MM, Greenhalf W, Stocken DD, Ellis I, Simon P, Truninger K, Ammann R, Cavallini G, Charnley RM, Uomo G, Delhaye M, Spicak J, Drumm B, Jansen J, Mountford R, Whitcomb DC, Neoptolemos JP;  European Registry of Hereditary Pancreatitis and Pancreatic Cancer (EUROPAC). Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol. 2004;2:252-261. [PMID: 15017610 DOI: 10.1016/s1542-3565(04)00013-8] [Cited by in Crossref: 417] [Cited by in F6Publishing: 350] [Article Influence: 23.2] [Reference Citation Analysis]
24 Teich N, Le Maréchal C, Kukor Z, Caca K, Witzigmann H, Chen JM, Tóth M, Mössner J, Keim V, Férec C. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2). Hum Mutat. 2004;23:22-31. [PMID: 14695529 DOI: 10.1002/humu.10285] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
25 Alexakis N, Ghaneh P, Connor S, Raraty M, Sutton R, Neoptolemos JP. Duodenum- and spleen-preserving total pancreatectomy for end-stage chronic pancreatitis. British Journal of Surgery 2003;90:1401-8. [DOI: 10.1002/bjs.4324] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
26 Charnley RM. Hereditary pancreatitis. World J Gastroenterol 2003; 9(1): 1-4 [PMID: 12508340 DOI: 10.3748/wjg.v9.i1.1] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
27 Ulrich CD. Pancreatic cancer in hereditary pancreatitis: consensus guidelines for prevention, screening and treatment. Pancreatology. 2001;1:416-422. [PMID: 12120218 DOI: 10.1159/000055841] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 3.1] [Reference Citation Analysis]
28 Threadgold J, Greenhalf W, Ellis I, Howes N, Lerch MM, Simon P, Jansen J, Charnley R, Laugier R, Frulloni L, Oláh A, Delhaye M, Ihse I, Schaffalitzky de Muckadell OB, Andrén-Sandberg A, Imrie CW, Martinek J, Gress TM, Mountford R, Whitcomb D, Neoptolemos JP. The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut 2002;50:675-81. [PMID: 11950815 DOI: 10.1136/gut.50.5.675] [Cited by in Crossref: 153] [Cited by in F6Publishing: 138] [Article Influence: 7.7] [Reference Citation Analysis]
29 Teich N, Bauer N, Mössner J, Keim V. Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants. Am J Gastroenterol 2002;97:341-6. [PMID: 11866271 DOI: 10.1111/j.1572-0241.2002.05467.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 25] [Article Influence: 0.1] [Reference Citation Analysis]
30 Simon P, Weiss FU, Sahin-Toth M, Parry M, Nayler O, Lenfers B, Schnekenburger J, Mayerle J, Domschke W, Lerch MM. Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122 --& gt; Cys) that alters autoactivation and autodegradation of cationic trypsinogen. J Biol Chem. 2002;277:5404-5410. [PMID: 11719509 DOI: 10.1074/jbc.m108073200] [Cited by in Crossref: 83] [Cited by in F6Publishing: 75] [Article Influence: 4.0] [Reference Citation Analysis]
31 Le Maréchal C, Chen JM, Quéré I, Raguénès O, Férec C, Auroux J. Discrimination of three mutational events that result in a disruption of the R122 primary autolysis site of the human cationic trypsinogen (PRSS1) by denaturing high performance liquid chromatography. BMC Genet. 2001;2:19. [PMID: 11734061 DOI: 10.1186/1471-2156-2-19] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
32 Etemad B, Whitcomb DC. Chronic pancreatitis: Diagnosis, classification, and new genetic developments. Gastroenterology 2001;120:682-707. [DOI: 10.1053/gast.2001.22586] [Cited by in Crossref: 816] [Cited by in F6Publishing: 705] [Article Influence: 38.9] [Reference Citation Analysis]